ZTSZoetis
$74.04-2.33%Real quote · delayedAnimal health🏛️ Company factsSEC filings + FINRA official data
Annual revenue $9.5B · latest quarter down 0.2% YoY · profitable (FY net income $2.7B) · short activity within its normal range.
FY revenue
$9.5B
2025-12
Latest Q YoY
-0.2%
FY net income
$2.7B
Diluted EPS
$6.03
Short volume
43%
20d avg 40.7% · normal
🐋 5%+ ownership filings (last 180d)
The parties below hold over 5% of this company and disclosed it to the SEC (mandatory in US markets). "Activist" filers state an intent to influence the company; "Passive" are pure investment positions.
- 2026-07-30passive (13G)BlackRock, Inc.
- 2026-04-30passive (13G)VANGUARD CAPITAL MANAGEMENT LLC
- 2026-04-29passive (13G)VANGUARD PORTFOLIO MANAGEMENT LLC
- 2026-03-27passive (13G)VANGUARD GROUP INC
🎯 Market expectations
Expectation reliability High · 72/100Nasdaq analyst consensus · the pre-news baseline
- Jun 2026$1.87 vs $1.84+1.63%
- Mar 2026$1.53 vs $1.61-4.97%
- Dec 2025$1.48 vs $1.40+5.71%
- Sep 2025$1.70 vs $1.62+4.94%
The takeaway
It has tracked consensus closely — no systematic over- or under-shooting. Analysts cut estimates 7× in 4 weeks.
Analyst estimates, not our forecast · not investment advice
What's moving this stock lately
No recent news affecting this stock
🕰️ Price × news · engine report card
Drag to pan, scroll to zoom · real daily bars and volume
📜 Call history (newest first
3 engine calls on this stock — each with direction, magnitude and its verified outcome · sign up to view
Sign up · free 7-day trial →Impact chains · crowding · conviction engine · insider signals — free 7-day trial on signup.
Sign up · free 7-day trial →